Table 3 Treatment of patients and response to treatment.
n | Range, % | |
|---|---|---|
Route of administration | ||
iv | 330 | 64.3 |
sc | 183 | 35.7 |
Time to treatment (months, median) | 1.2 | 0.1–261.8 |
Blood count recovery | ||
White blood cell count (day, median) | 30 | 4–302 |
Platelet count (day, median) | 22 | 6–300 |
Hemoglobin (day, median) | 50 | 7–182 |
Time to evaluation of response (months, median) | 3.3 | 0.3–9.8 |
Response | ||
CR | 335 | 65.3 |
PR | 96 | 18.7 |
HR | 40 | 7.8 |
NR | 42 | 8.2 |
Second course | 25 | |
CR | 13 | 52 |
PR | 5 | 20 |
HR | 2 | 8 |
NR | 5 | 20 |
Status | ||
Alive | 464 | 90.5 |
Dead | 49 | 9.5 |
OS at 25 years, % | 66 | 50.7–85.6 |
